Cancer News
OncoLink Cancer News - HealthDay

Pregabalin Can Reduce Hot Flash Frequency and Severity

-- A. Agrawal, PhD

Thursday, November 12, 2009

THURSDAY, Nov. 12 (HealthDay News) -- Pregabalin (Lyrica) is as effective as other drugs in reducing the frequency and severity of hot flashes, according to a study published online Nov. 9 in the Journal of Clinical Oncology.

Charles L. Loprinzi, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues randomly assigned 163 women with bothersome hot flashes (severe and at least 28 times per week) to pregabalin at 75 or 150 mg twice daily or placebo.

At six weeks, the researchers found that hot flash scores fell by 50 percent in the placebo group, by 65 percent for 75 mg pregabalin, and by 71 percent for 150 mg pregabalin. Pregabalin was generally well tolerated, although some toxicities were significantly more common in patients receiving pregabalin.

"Pregabalin decreases hot flashes and is reasonably well tolerated," Loprinzi and colleagues conclude. "Its effects appear to be roughly comparable to what has been reported with gabapentin and with some newer antidepressants."

Full Text (subscription or payment may be required)

Specialties Cardiology
Diabetes & Endocrinology
Internal Medicine
Family Practice

Copyright © 2009 ScoutNews, LLC. All rights reserved.

I Wish You Knew

How an oncology social worker can improve your cancer experience

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More